{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:00:45Z","timestamp":1778943645802,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jjcc.2023.07.015","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T06:18:54Z","timestamp":1691043534000},"page":"163-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["5-year stroke rates in nonvalvular atrial fibrillation after watchman compared to direct oral anticoagulants"],"prefix":"10.1016","volume":"83","author":[{"given":"Syed I.","family":"Khalid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyama","family":"Sathianathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle B.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Stone","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona C.","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit I.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2023.07.015_bb0005","unstructured":"WATCHMAN: Left Atrial Appendage Closure Device. https:\/\/www.watchman.com\/."},{"issue":"1","key":"10.1016\/j.jjcc.2023.07.015_bb0010","doi-asserted-by":"crossref","DOI":"10.5334\/gh.1023","article-title":"World heart federation roadmap on atrial fibrillation \u2013 a 2020 update","volume":"16","author":"Freedman","year":"2021","journal-title":"Glob Heart"},{"issue":"1","key":"10.1016\/j.jjcc.2023.07.015_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000279","article-title":"NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis","volume":"3","author":"Hicks","year":"2016","journal-title":"Open Heart"},{"issue":"9","key":"10.1016\/j.jjcc.2023.07.015_bb0020","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jjcc.2023.07.015_bb0025","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jjcc.2023.07.015_bb0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2023.07.015_bb0035","first-page":"17","article-title":"Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials","author":"Wu","year":"2021","journal-title":"J Neurol Publ Online Febr"},{"issue":"25","key":"10.1016\/j.jjcc.2023.07.015_bb0040","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jjcc.2023.07.015_bb0045","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.jacc.2020.08.089","article-title":"Left atrial appendage closure versus oral anticoagulants in atrial fibrillation: a Meta-analysis of randomized trials","volume":"76","author":"Turagam","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jjcc.2023.07.015_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"Nielsen-Kudsk","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2023.07.015_bb0055","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-19-00507","article-title":"Percutaneous left atrial appendage closure versus nonvitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk","author":"Godino","year":"2020","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.jjcc.2023.07.015_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jjcc.2023.07.015_bb0065","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER cardiac plug","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1016\/j.jjcc.2023.07.015_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014108","article-title":"Rates of potentially inappropriate dosing of direct-acting oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: the SAGE-AF study","volume":"9","author":"Sanghai","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.jjcc.2023.07.015_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003074","article-title":"Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation","volume":"5","author":"Yao","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jjcc.2023.07.015_bb0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(03)00266-7","article-title":"Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century","volume":"2","author":"Feigin","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jjcc.2023.07.015_bb0085","first-page":"93","article-title":"Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation","volume":"8","author":"Tawfik","year":"2016","journal-title":"Clin Pharm"},{"issue":"24","key":"10.1016\/j.jjcc.2023.07.015_bb0090","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jjcc.2023.07.015_bb0095","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/STROKEAHA.118.023722","article-title":"Intracerebral hemorrhage formation under direct oral anticoagulants","volume":"50","author":"Foerch","year":"2019","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.jjcc.2023.07.015_bb0100","first-page":"1577","article-title":"Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA registry","volume":"20","author":"Ruiz Ortiz","year":"2018","journal-title":"EP Eur"},{"key":"10.1016\/j.jjcc.2023.07.015_bb0105","unstructured":"Blackshear JL, Odell A. Appendage Obliteration to Reduce Stroke in Cardiac Surgical Patients With Atrial Fibrillation."}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508723001818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508723001818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:09:59Z","timestamp":1760274599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508723001818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0914508723001818"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2023.07.015","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-year stroke rates in nonvalvular atrial fibrillation after watchman compared to direct oral anticoagulants","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2023.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}